Dugesia dorotocephala

1. ARV-825 decreases viability in D. dorotocephala (91.7% survival with 1μM ARV-825 reduced to 25% survival in 10 μM ARV-825).

   “This demonstrated a concentration-dependent reduction in viability, 91.7% survival with 1μM ARV-825 reduced to 25% survival in 10 μM ARV-825.”

   Model organisms

   Viability of Dugesia dorotocephala Planaria with the Senolytic Drug ARV-825

   microPublication biology·6 Feb 2026

More on ARV-825